Videstim® (Ointment) Instructions for Use
Marketing Authorization Holder
Retinoids JSC (Russia)
ATC Code
D10AD02 (Retinol)
Active Substance
Retinol (Rec.INN registered by WHO)
Dosage Form
| Videstim® | Ointment for external use 0.5%: 10 g, 15 g, 20 g or 35 g tubes |
Dosage Form, Packaging, and Composition
Ointment for external use homogeneous, from white to light yellow in color.
| 1 g | |
| Retinol palmitate (vit. A) | 5 mg |
Excipients: butylated hydroxytoluene – 0.5 mg, butylated hydroxyanisole – 0.25 mg, emulsifying wax – 80 mg, mineral oil – 80 mg, glycerol (glycerin) – 100 mg, ethanol 95% – 100 mg, purified water – up to 1 g.
10 g – aluminum tubes (1) – cardboard packs.
15 g – aluminum tubes (1) – cardboard packs.
20 g – aluminum tubes (1) – cardboard packs.
35 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Drug for moisturizing and protecting the cornea
Pharmacotherapeutic Group
Vitamin
Pharmacological Action
Vitamin A belongs to the fat-soluble vitamins.
When applied externally, it stimulates skin regeneration, enhances the proliferation of skin epithelial cells, inhibits keratinization processes, and prevents the development of hyperkeratosis. The action is due to the presence of specific retinol-binding receptors on the surface of epithelial cells.
Pharmacokinetics
Retinol easily penetrates the skin. Cmax is reached 3-4 hours after application and is maintained for 12 hours. T1/2 is 5.5 hours.
Indications
Inflammatory and degenerative diseases and conditions of the skin accompanied by dryness and slow healing (as part of complex therapy or as monotherapy): dermatitis, eczema, atopic dermatitis without exacerbation, cheilitis, fissures (including nipple fissures) and abrasions, age-related skin changes, as well as diseases associated with impaired keratinization processes. Used to activate reparative processes in various dermatoses after discontinuation of corticosteroid therapy. Frostbite, burns, wounds, ichthyosis.
ICD codes
| ICD-10 code | Indication |
| K13.0 | Diseases of lips |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L30.0 | Nummular eczema |
| L30.9 | Dermatitis, unspecified |
| L85.0 | Acquired ichthyosis |
| L85.1 | Acquired keratosis [keratoderma] palmaris et plantaris |
| L85.2 | Punctate keratosis (palmar-plantar) |
| L90.9 | Unspecified atrophic skin change |
| N64.0 | Fissure and fistula of nipple |
| O92.1 | Cracked nipple associated with childbirth |
| R23.4 | Changes in skin texture |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T30 | Burns and corrosions of unspecified body region |
| T33 | Superficial frostbite |
| ICD-11 code | Indication |
| 9A06.70 | Atopic eczema of the eyelids |
| DA00.Z | Diseases of lips, unspecified |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EA85.20 | Atopic hand eczema |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EC20.32 | Papular palmoplantar keratodermas |
| ED50.0 | Acquired ichthyosis |
| ED55.0 | Acquired palmoplantar keratodermas |
| EE21 | Epidermal fragility |
| EE40.Z | Atrophy or degeneration of connective tissue of dermis or subcutaneous fat, unspecified |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| GB23.1 | Fissure or fistula of nipple |
| JB46.1 | Cracked nipple associated with childbirth |
| KC30 | Fragile skin of prematurity |
| ME66.1 | Changes in skin texture |
| ND56.0 | Superficial injury of unspecified body region |
| NE11 | Burn of unspecified body region |
| NE40 | Superficial frostbite |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply a thin layer of ointment to the affected skin areas twice daily, in the morning and evening.
Prior to application, cleanse and dry the affected skin area thoroughly.
The duration of treatment is determined by the severity of the condition and the rate of clinical improvement.
For chronic dermatoses and ichthyosis, apply the ointment for several weeks.
For cracked nipples, apply after each feeding; wash off thoroughly before the next feeding.
For wounds, burns, and frostbite, apply under a sterile gauze dressing.
Avoid contact with eyes, mucous membranes, and open wounds.
Discontinue use and consult a physician if severe skin irritation or signs of an allergic reaction occur.
Do not use concurrently with other topical retinoid preparations to prevent overdose.
For external use only.
Adverse Reactions
In some cases increased itching and redness of the skin at the application site.
Possible allergic reactions.
Contraindications
Hypersensitivity to retinol, hypervitaminosis A, acute inflammatory skin diseases.
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding is possible in cases where the expected benefit of therapy for the mother outweighs the potential risk to the fetus and breastfed infant.
Use in Renal Impairment
.
Pediatric Use
Contraindicated for use in children under 7 years of age.
Geriatric Use
Use with caution in elderly patients.
Special Precautions
No more than one preparation containing Retinol should be used simultaneously to avoid overdose.
Drug Interactions
Incompatible with tetracycline antibiotics.
Storage Conditions
Store at 2°C (36°F) to 8°C (46°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Picamilon pills 50mg, 60pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Phenibut-Vertex pills 250mg, 20pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Fenotropil pills 100mg, 60pcs
Mildronate capsules 500mg, 90pcs
Cortexin, 10mg, 5ml, 10pcs
Kagocel pills 12mg, 30pcs
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs
Actovegin pills 200mg, 50pcs
Belosalic, lotion solution for external use spray 100ml 